Inter Pharma Public Company Limited

SET:IP Stock Report

Market Cap: ฿1.8b

Inter Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Trinnawat Thanitnithiphan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.4yrs
CEO ownership31.2%
Management average tenure3.2yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

CEO

Trinnawat Thanitnithiphan

4.4yrs

Tenure

Dr. Trinnawat Thanitnithiphanm is the Independent Director at P.S.P. Specialties Public Company Limited since 2023. He formally known as Songwut Sakchalathorn serves as Director at Interpharma Public Compa...

Leadership Team

NamePositionTenureCompensationOwnership
Trinnawat Thanitnithiphan
CEO & Directorno datano data31.2%
THB 570.4m
Chatkaew Krudkosol
Acting CFO & Acting Director of Accounting1.6yrsno datano data
Napaporn Dechakarat
Director of Operations & Directorno datano datano data
Apimon Posri
Human Resources Director & Director4.4yrsno datano data
Chompunuch Meevang
Company Secretary3.2yrsno datano data

3.2yrs

Average Tenure

Experienced Management: IP's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Trinnawat Thanitnithiphan
CEO & Director4.4yrsno data31.2%
THB 570.4m
Napaporn Dechakarat
Director of Operations & Director4.4yrsno datano data
Apimon Posri
Human Resources Director & Director2.5yrsno datano data
Udom Kachintorn
Independent Chairman of the Board5.1yrs฿608.82kno data
Sansanee Chaiyaroj
Independent Director4.4yrs฿533.82kno data
Kamtorn Sila-On
Independent Director3.9yrs฿563.82kno data
Pao Sriprasertsuk
Independent Director3.2yrs฿508.82kno data
Nat Ativitavas
Director2.4yrs฿364.71kno data
Yuttana Suwannachot
Director1.9yrs฿290.00kno data

3.9yrs

Average Tenure

Experienced Board: IP's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 13:13
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inter Pharma Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution